IL146417A0 - Ox2 receptor homologs - Google Patents

Ox2 receptor homologs

Info

Publication number
IL146417A0
IL146417A0 IL14641700A IL14641700A IL146417A0 IL 146417 A0 IL146417 A0 IL 146417A0 IL 14641700 A IL14641700 A IL 14641700A IL 14641700 A IL14641700 A IL 14641700A IL 146417 A0 IL146417 A0 IL 146417A0
Authority
IL
Israel
Prior art keywords
receptor homologs
homologs
receptor
Prior art date
Application number
IL14641700A
Other languages
English (en)
Original Assignee
Medical Res Council
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9911123.9A external-priority patent/GB9911123D0/en
Priority claimed from GBGB9925989.7A external-priority patent/GB9925989D0/en
Application filed by Medical Res Council, Schering Corp filed Critical Medical Res Council
Publication of IL146417A0 publication Critical patent/IL146417A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
IL14641700A 1999-05-13 2000-05-11 Ox2 receptor homologs IL146417A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9911123.9A GB9911123D0 (en) 1999-05-13 1999-05-13 Materials and methods relating to a membrane-bound cell surface protein
GBGB9925989.7A GB9925989D0 (en) 1999-11-03 1999-11-03 Mammalian proteins; related reagents and methods
PCT/US2000/012998 WO2000070045A1 (en) 1999-05-13 2000-05-11 Ox2 receptor homologs

Publications (1)

Publication Number Publication Date
IL146417A0 true IL146417A0 (en) 2002-07-25

Family

ID=26315542

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14641700A IL146417A0 (en) 1999-05-13 2000-05-11 Ox2 receptor homologs

Country Status (13)

Country Link
US (3) US20060084121A1 (ja)
EP (3) EP2341143A1 (ja)
JP (3) JP2002543838A (ja)
KR (5) KR101005124B1 (ja)
CN (1) CN1372594A (ja)
AU (1) AU5007200A (ja)
CA (1) CA2372549A1 (ja)
HK (1) HK1044023A1 (ja)
HU (1) HUP0203805A3 (ja)
IL (1) IL146417A0 (ja)
MX (1) MXPA01011519A (ja)
NZ (1) NZ515382A (ja)
WO (1) WO2000070045A1 (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030166109A1 (en) * 1997-09-18 2003-09-04 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1683865A3 (en) * 2001-02-02 2006-10-25 Eli Lilly & Company Mammalian proteins and in particular CD200
US7186818B2 (en) 2001-04-26 2007-03-06 Immunex Corporation DNA encoding soluble variants of human OX2 receptors
US7368535B2 (en) * 2001-05-24 2008-05-06 Trillium Therapeutics Inc. CD200 receptors
JP4381140B2 (ja) 2001-10-12 2009-12-09 シェーリング コーポレイション 免疫応答を調節するための二重特異性抗体の使用
WO2003077947A1 (en) * 2002-03-15 2003-09-25 Schering Corporation Methods of modulating cd200 receptors
WO2004060295A2 (en) * 2002-12-27 2004-07-22 Schering Corporation Methods of inducing and maintaining immune tolerance
WO2004072648A1 (en) * 2003-02-17 2004-08-26 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g protein-coupled receptor ox2r (ox2r)
AR064610A1 (es) 2006-12-22 2009-04-15 Schering Corp Anticuerpos contra el cd200r
US8585870B2 (en) * 2008-03-05 2013-11-19 E I Du Pont De Nemours And Company Process to C-manufacture acrylonitrile and hydrogen cyanide
EP4157461A1 (en) 2020-05-29 2023-04-05 23Andme, Inc. Anti-cd200r1 antibodies and methods of use thereof

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US244052A (en) * 1881-07-12 Railroad-gate
US169870A (en) * 1875-11-09 Improvement in potato-diggers
US223991A (en) * 1880-02-03 Parent office
US213783A (en) * 1879-04-01 Improvement in hot-air engines
FR2046920B1 (ja) 1969-06-19 1974-05-03 Citizen Watch Co Ltd
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4859609A (en) 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US7339033B2 (en) * 1998-06-26 2008-03-04 Genentech, Inc. Pro1481
EP1100869A4 (en) * 1998-07-30 2005-04-27 Human Genome Sciences Inc 98 HUMAN SECRETED PROTEINS
AU6802801A (en) * 2000-03-01 2001-09-24 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2003077947A1 (en) * 2002-03-15 2003-09-25 Schering Corporation Methods of modulating cd200 receptors
WO2004060295A2 (en) * 2002-12-27 2004-07-22 Schering Corporation Methods of inducing and maintaining immune tolerance
US20070244052A1 (en) * 2003-12-19 2007-10-18 Schering Corporation Methods for Identifying Agonists or Antagonists of CD200R Signaling Molecules and Methods of Using the Same
WO2005074985A2 (en) * 2004-02-02 2005-08-18 Schering Corporation Methods of modulating cd200 and cd200r
AR064610A1 (es) * 2006-12-22 2009-04-15 Schering Corp Anticuerpos contra el cd200r
US11068393B2 (en) 2019-10-17 2021-07-20 Microsoft Technology Licensing, Llc Enhanced concurrency garbage collection stack scanning

Also Published As

Publication number Publication date
KR20090025341A (ko) 2009-03-10
KR20020047036A (ko) 2002-06-21
KR20110102476A (ko) 2011-09-16
CN1372594A (zh) 2002-10-02
KR20100123890A (ko) 2010-11-25
EP2341143A1 (en) 2011-07-06
EP1177295A1 (en) 2002-02-06
US20060084121A1 (en) 2006-04-20
KR101018134B1 (ko) 2011-02-25
US20090012270A1 (en) 2009-01-08
MXPA01011519A (es) 2003-08-20
HK1044023A1 (zh) 2002-10-04
JP2007319163A (ja) 2007-12-13
CA2372549A1 (en) 2000-11-23
JP2012072186A (ja) 2012-04-12
KR20090133133A (ko) 2009-12-31
AU5007200A (en) 2000-12-05
JP2002543838A (ja) 2002-12-24
HUP0203805A2 (hu) 2003-03-28
EP2336321A1 (en) 2011-06-22
NZ515382A (en) 2004-03-26
US20120231003A1 (en) 2012-09-13
WO2000070045A1 (en) 2000-11-23
HUP0203805A3 (en) 2012-09-28
KR101005124B1 (ko) 2011-01-04
KR101018176B1 (ko) 2011-02-28

Similar Documents

Publication Publication Date Title
EP1189609A4 (en) CXCR-4 RECEPTOR ANTAGONISTS AND THROMBOPOIETIN MIMETIKA
GB0015176D0 (en) Early entry
GB0016917D0 (en) Early entry
GB0126363D0 (en) Early entry
EP1151955A4 (en) ELEVATOR DEVICE
GB9903767D0 (en) Receptor assay
IL146151A0 (en) Human-g-protein receptor
HUP0203805A3 (en) Ox2 receptor homologs
EG24025A (en) Vitronectin receptor antagonist
IL154654A0 (en) Osteoclast-associated receptor
GB0205052D0 (en) Early entry
EP1084142A4 (en) GPR35A RECEIVER
GB0025045D0 (en) Early Entry
GB0000474D0 (en) Receptor
EP1223946A4 (en) HUMAN NEUROPEPTIDE RECEPTOR
IL154317A0 (en) Imidazoline receptor homologs
GB9927215D0 (en) Hormone receptor expression
GB0007274D0 (en) Lavatories
GB0023554D0 (en) Early entry
GB0031096D0 (en) Receptor
GB0114929D0 (en) Receptor
GB0110662D0 (en) Receptor
GB0111959D0 (en) Receptor
GB0125183D0 (en) Receptor
GB0107914D0 (en) 7tm receptor hlwar77